Clinical Trials · NCT02431325
A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 32
- Start date
- Dec 2015
- Locations
- 1 site, United States
- Primary endpoint
- Change in Arterial Target to Background Ratio of 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Uptake